Entheon Biomedical Corp. (TSE:ENBI) has released an update.
Entheon Biomedical Corp. has successfully completed a private placement, raising $147,500 through the issuance of 2,950,000 units at $0.05 each, with each unit comprising a common share and a share purchase warrant. The funds will bolster the company’s working capital, with the newly issued securities being subject to a four-month hold period. Entheon Biomedical focuses on developing treatments for addiction and substance use disorders.
For further insights into TSE:ENBI stock, check out TipRanks’ Stock Analysis page.
